Unlocking new ways to treat every patient
We have half a century of experience and expertise in matching donors, saving lives and transforming futures for patients. But we’re still learning, still growing and still pushing the boundaries. We know there is so much more that can be done and we’re ambitious about doing it. So our strategy is ambitious too.
A word from our CEO, Henny Braund
Our history
Over the next five years we’re determined to embrace the opportunities and innovations that we know will change the outcomes for so many more patients. Because they need and deserve nothing less. This pioneering spirit is what inspired Shirley Nolan in 1974 and is what still drives us today. It’s part of our natural evolution as an organisation and it’s our duty to continue to build on her incredible legacy.
Over the next five years we’re determined to embrace the opportunities and innovations that we know will change the outcomes for so many more patients. Because they need and deserve nothing less. This pioneering spirit is what inspired Shirley Nolan in 1974 and is what still drives us today. It’s part of our natural evolution as an organisation and it’s our duty to continue to build on her incredible legacy.
Our vision
A future where every patient who needs us can survive and thrive.
Our purpose
Uniting people and science to unlock the cures, treatments and transplants that will transform the future for more patients.
Our aims
We are excited about what the future holds for our work and for every patient who needs a stem cell transplant or cell therapy. We have a lot to do but over the next five years we will focus particularly on the three areas of our work where we think we can have the greatest impact, and make the biggest difference for the most people.
Aim 1 – Survival
To give every transplant patient the best chance - and quality - of life.
Aim 2 – Equity
To ensure all patients have the best access to, experience of and outcome from, treatment.
Aim 3 – Progress
To explore and embrace new cell therapies and make them available for patients more quickly.
Alyssa, 13, is the first patient in the world reported to have received a base-edited cell therapy to treat her resistant leukaemia. She was enrolled on to a new clinical trial involving genetically modified CAR T-cells at Great Ormond Street Hospital to treat her ‘incurable’ cancer. Just 28 days after receiving the modified T-cells, Alyssa was in remission! Without this experimental treatment, her only option would have been palliative care.
Find out more
Read more about our incredible patients and the strategy that will help us achieve so much more for them.
How we’ll achieve our aims
We’ll use the most powerful tools we have available to make these ambitions a reality:
- Discovery – Our pioneering research helps us push boundaries and influence for change.
- Data – Gathering and understanding rich data gives us vital insight into each patient’s needs.
- Donors – Anthony Nolan’s work simply wouldn’t be possible without our incredible donors.
Be part of something amazing
We hope you’ll want to join us in these exciting future plans. Here are three easy ways you can be part of it and start saving lives today.
- Spread the word
Want to help us reach more supporters? Share this strategy with anyone you think will listen. Follow us on social media and get your friends on board too.
- Join the register
If you’re aged 16-30, follow this link to see if you’re eligible to sign up as a potential donor. We’ll send you a swab kit if you are and you’ll be joining our incredible community of potential lifesavers. - Raise funds
Whether you want to run a marathon, organise a cake sale or donate some of your salary at source, our fundraising team is ready to hear from you here.
Find out more
If you want to know more about Anthony Nolan and our ambitious plans to transform the lives of our patients now and in the future, read our full five-year organisational strategy: